Analysis for TF and EPCR expression showed that irrespective of the implanted tumor cell population, the majority of outgrown tumor cells presented with a EPCR−/TFhigh phenotype (Fig. 3C), indicating a conversion from EPCR+ to EPCR− cells in the tumor microenvironment in vivo. The gene discussed is PROCR; the disease is neoplasm.